Concepedia

Filippo Pietrantonio

FP

221

Publications

11.8K

Citations

52

H-Index

1990

Active since

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

Istituto Oncologico Veneto

Azienda Ospedaliera Universitaria Pisana

Istituti di Ricovero e Cura a Carattere Scientifico

University of Milan

Filippo Pietrantonio is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

1990–2025

221

Publications

221

Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth

Giovanni Germano, Simona Lamba, Giuseppe Rospo et al. · Nature · 2017 · 608 citations

, , +12

Rechallenge for Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan

Chiara Cremolini, Daniele Rossini, Emanuela Dell’Aquila et al. · JAMA Oncology · 2018 · 397 citations · Full text

Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients

Lisa Derosa, Bertrand Routy, Marine Fidelle et al. · European Urology · 2020 · 349 citations · Full text

, , +10

ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer

Filippo Pietrantonio, Federica Di Nicolantonio, Alexa B. Schrock et al. · JNCI Journal of the National Cancer Institute · 2017 · 322 citations · Full text

The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials

Giovanni Fucà, Vincenzo Guarini, Carlotta Antoniotti et al. · British Journal of Cancer · 2020 · 315 citations · Full text

Rows per page

1–5 of 221